Plant-based enteral nutrition products

The problem

Patients needing enteral nutrition suffer high intolerance rates from existing products without alternatives.

The solution

Developing more easily digestible and tolerable plant-based enteral nutrition products to improve patient well-being and health.

Our engagement

Anterra participated in the Series C financing round alongside Novo Holdings, Kaiser Permanente Ventures, Coefficient Capital, Aliment Capital, Eaglehead Capital, Main Street Advisors, and Goldman Sachs Asset Management.